Ethyl 2-(5-chloro-2-methyl-1H-indol-3-yl)acetate, 97%, 1g

3-(3'-Pyridyl)phenylacetic acid, 95.0%, 1g

Enalapril Maleate>98.0%(HPLC)(T)5g

2-(2,6-Dioxopiperidin-3-yl)-1-oxoisoindoline-5-carbaldehyde, 98%, 100mg

9-[4-Acetoxy-3-(hydroxymethyl)but-1-yl]-2-aminopurine, 95%, 100mg

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 3.00 µm, 1 Piece(s)

4-Methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 10g

2-(8-AMINO-1,4-DIOXASPIRO[4.5]DECAN-8-YL)ACETIC ACID, 95.0%, 500mg

(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)-4-methoxytetrahydrofuran-3-ol, 98%, 250mg

Boc-Ala-OH, 98%, 100g

3,3''-Di(9H-carbazol-9-yl)-1,1':3',1''-terphenyl>97.0%(HPLC)(N)200mg

2-Iodo-4-methylaniline, 95.0%, 5g

3'-Azido-2'3'-ddCTP, ≥95%, 500 µl, plastic packaging.